---
title: Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding
nct_id: NCT06070792
overall_status: COMPLETED
phase: NA
sponsor: Aysegul Kilicli
study_type: INTERVENTIONAL
primary_condition: NEUROLINGUISTIC PROGRAMMING
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06070792.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06070792"
ct_last_update_post_date: 2024-09-19
last_seen_at: "2026-05-12T06:33:17.884Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding

**Official Title:** The Effect of Neuro Linguistic Program and Progressive Muscle Relaxation Exercises on Breastfeeding Success and Breastfeeding Self-efficacy After Caesarean Section

**NCT ID:** [NCT06070792](https://clinicaltrials.gov/study/NCT06070792)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 99
- **Lead Sponsor:** Aysegul Kilicli
- **Conditions:** NEUROLINGUISTIC PROGRAMMING, PROGRESSIVE MUSCLE RELAXATION EXERCISES, CAESAREAN SECTION
- **Start Date:** 2023-10-01
- **Completion Date:** 2023-12-18
- **CT.gov Last Update:** 2024-09-19

## Brief Summary

The effect of neuro linguistic program and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy after caesarean section.

## Detailed Description

In this research, it is aimed to detemine the effect of neuro linguistic program and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy after caesarean section.

Sample size:

* There will be three groups in the study (two experimental groups and one control group).
* The sample size of the study is 99 people. The sample size will be divided into three and 33 people will be randomly assigned to each group.
* Experiment 1 group: neuro linguistic programme (NLP) group.
* Experiment 2 group: progressive muscle relaxation exercises (PMRE) group.
* Control group: non-intervention group

Data Collection Tools;

* Introductory Information Form,
* Breastfeeding Self-Efficacy Scale,
* Breastfeeding Charting System (LATCH)

Application time:

* NLP and PMRE interventions will be started at the sixth postoperative hour after caesarean section.
* Mothers who give birth by caesarean section are followed up in hospital for 48 hours and mothers are then discharged when their health condition improves. Therefore, data will be collected within 48 hours after caesarean section.
* NLP and PMRE groups will be started at the sixth postoperative hour, 3 times in 24 hours on the first day, 3 times in 24 hours on the second day, six times in total.
* Only NLP and PMRE will not be applied to the control group.
* Care and follow-up will be performed in parallel with the individuals in the experimental group.

Measurement time:

* Mothers will fill in the Introductory Information Form, Breastfeeding Self-Efficacy Scale, Breastfeeding Diagnosis and Assessment Measurement Tool (LATCH) before the application at the sixth postoperative hour.
* Then, in the first 24 hours, the necessary application will be performed once every eight hours according to the groups (for example, NLP application for experiment 1).
* At the end of 24th hour, Breastfeeding Self-Efficacy Scale and Breastfeeding Diagnosis and Assessment Measurement Tool (LATCH) will be completed.
* Then, in the second 24 hours, the interventions will be repeated once every eight hours.
* The total number of application sessions is six.
* NLP application will last 20 minutes each session and PMRE application will last 20 minutes each session.

## Eligibility

- **Minimum age:** 19 Years
- **Maximum age:** 35 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* women who gave birth by caesarean section,
* primiparous,
* who are 19 years of age or older and 35 years of age or younger,
* who were born at 37 or more weeks of gestation,
* who had a singleton birth,
* whose caesarean section operation was performed with spinal anaesthesia,
* who do not have chronic diseases and any breast-related health problems .

Exclusion Criteria:

* mothers who did not meet the inclusion criteria,
* who wanted to leave the study voluntarily at any stage after being included in the study,
* who developed any health problems in themselves or their infants were excluded.
```

## Arms

- **NEURO LINGUISTIC PROGRAM** (EXPERIMENTAL) — first experimental group. It will be administered to primiparous mothers after caesarean section in the first 48 hours after the sixth postoperative hour, once every eight hours, for a total of six times. Each session will last 20 minutes.

In the NLP application; firstly, the most frequently used visual, auditory and/or tactile representation system of the woman will be determined. Then, the internal and external reactions caused by the symptoms after caesarean section, her feelings and thoughts about her baby and breastfeeding will be combined with the anchoring technique. Then, with the swish technique, the existing negative emotions will be reduced and tried to be deleted from the most frequently used representation system. The woman's negative thoughts about breastfeeding will be changed in a positive direction with the belief change model.
- **PROGRESSIVE MUSCLE RELAXATION EXERCISES** (EXPERIMENTAL) — second experimental group. It will be administered to primiparous mothers after caesarean section in the first 48 hours after the sixth postoperative hour, once every eight hours, for a total of six times. Each session will last 20 minutes.

PMRE; All muscles of the body will be tried to be relaxed respectively with the commands given gradually.
- **control** (NO_INTERVENTION) — The control group will not receive NLP or PMRE.

## Interventions

- **NEURO LINGUISTIC PROGRAM** (OTHER) — NEURO LINGUISTIC PROGRAM
- **PROGRESSIVE MUSCLE RELAXATION EXERCISES** (OTHER) — PROGRESSIVE MUSCLE RELAXATION EXERCISES

## Primary Outcomes

- **BREASTFEEDING SUCCESS** _(time frame: immediately before the first application)_ — Breastfeeding Charting System (LATCH); The measurement tool has no cut-off point, and as the LATCH score increases, it is understood that the process is high. The maximum score that can be obtained is 10. The sum of lower scores indicates that the mother is dependent on help.
- **BREASTFEEDING SUCCESS** _(time frame: immediately after the third application (at the 24th hour after the first application))_ — Breastfeeding Charting System (LATCH)
- **BREASTFEEDING SUCCESS** _(time frame: immediately after the sixth application (at the 48th hour after the first application))_ — Breastfeeding Charting System (LATCH)
- **BREASTFEEDING SELF-EFFICACY** _(time frame: immediately before the first application)_ — Breastfeeding Self-Efficacy Scale; A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All are positive elements. The higher the score from the scale, the higher breastfeeding self-efficacy will be achieved.
- **BREASTFEEDING SELF-EFFICACY** _(time frame: immediately after the third application (at the 24th hour after the first application))_ — Breastfeeding Self-Efficacy Scale
- **BREASTFEEDING SELF-EFFICACY** _(time frame: immediately after the sixth application (at the 48th hour after the first application))_ — Breastfeeding Self-Efficacy Scale

## Locations (1)

- Şanlıurfa training and research hospital, Sanliurfa, Eyalet/Yerleşke, Turkey (Türkiye)

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.şanlıurfa training and research hospital|sanliurfa|eyalet/yerleşke|turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06070792.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06070792*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*